These are the sources and citations used to research PE endothelium. This bibliography was generated on Cite This For Me on

  • Journal

    Ahmad, S. and Ahmed, A.

    Antiangiogenic Effect of Soluble Vascular Endothelial Growth Factor Receptor-1 in Placental Angiogenesis

    2005 - Endothelium

    In-text: (Ahmad and Ahmed, 2005)

    Your Bibliography: Ahmad, S. and Ahmed, A., 2005. Antiangiogenic Effect of Soluble Vascular Endothelial Growth Factor Receptor-1 in Placental Angiogenesis. Endothelium, 12(1-2), pp.89-95.

  • Journal

    Bellamy, L., Casas, J., Hingorani, A. and Williams, D.

    Preeclampsia and Risk of Cardiovascular Disease and Cancer in Later Life: Systematic Review and Meta-analysis

    2008 - Obstetric Anesthesia Digest

    In-text: (Bellamy, Casas, Hingorani and Williams, 2008)

    Your Bibliography: Bellamy, L., Casas, J., Hingorani, A. and Williams, D., 2008. Preeclampsia and Risk of Cardiovascular Disease and Cancer in Later Life: Systematic Review and Meta-analysis. Obstetric Anesthesia Digest, 28(2), p.80.

  • Journal

    Chaiworapongsa, T., Romero, R., Espinoza, J., Bujold, E., Mee Kim, Y., Gonçalves, L. F., Gomez, R. and Edwin, S.

    Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia

    2004 - American Journal of Obstetrics and Gynecology

    In-text: (Chaiworapongsa et al., 2004)

    Your Bibliography: Chaiworapongsa, T., Romero, R., Espinoza, J., Bujold, E., Mee Kim, Y., Gonçalves, L., Gomez, R. and Edwin, S., 2004. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. American Journal of Obstetrics and Gynecology, 190(6), pp.1541-1547.

  • Journal

    Ferrara, N.

    Vascular Endothelial Growth Factor

    2009 - Arteriosclerosis, Thrombosis, and Vascular Biology

    In-text: (Ferrara, 2009)

    Your Bibliography: Ferrara, N., 2009. Vascular Endothelial Growth Factor. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(6), pp.789-791.

  • Journal

    Koga, K., Osuga, Y., Yoshino, O., Hirota, Y., Ruimeng, X., Hirata, T., Takeda, S., Yano, T., Tsutsumi, O. and Taketani, Y.

    Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia

    2003 - The Journal of Clinical Endocrinology & Metabolism

    In-text: (Koga et al., 2003)

    Your Bibliography: Koga, K., Osuga, Y., Yoshino, O., Hirota, Y., Ruimeng, X., Hirata, T., Takeda, S., Yano, T., Tsutsumi, O. and Taketani, Y., 2003. Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia. The Journal of Clinical Endocrinology & Metabolism, 88(5), pp.2348-2351.

  • Journal

    Levine, R., Qian, C., Maynard, S., Yu, K., Epstein, F., Karumanchi, S., Lim, K., Schisterman, E., Thadhani, R., Sachs, B., Sibai, B. and Sukhatme, V.

    Circulating angiogenic factors and the risk of preeclampsia*

    2004 - Obstetrics & Gynecology

    In-text: (Levine et al., 2004)

    Your Bibliography: Levine, R., Qian, C., Maynard, S., Yu, K., Epstein, F., Karumanchi, S., Lim, K., Schisterman, E., Thadhani, R., Sachs, B., Sibai, B. and Sukhatme, V., 2004. Circulating angiogenic factors and the risk of preeclampsia*. Obstetrics & Gynecology, 103(5, Part 1), p.993.

  • Journal

    Maynard, S. E., Min, J., Merchan, J., Lim, K., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., Epstein, F. H., Sukhatme, V. P. and Karumanchi, S. A.

    Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

    2003 - Journal of Clinical Investigation

    In-text: (Maynard et al., 2003)

    Your Bibliography: Maynard, S., Min, J., Merchan, J., Lim, K., Li, J., Mondal, S., Libermann, T., Morgan, J., Sellke, F., Stillman, I., Epstein, F., Sukhatme, V. and Karumanchi, S., 2003. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. Journal of Clinical Investigation, 111(5), pp.649-658.

  • Journal

    McKeeman, G. C., Ardill, J. E., Caldwell, C. M., Hunter, A. J. and McClure, N.

    Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop

    2004 - American Journal of Obstetrics and Gynecology

    In-text: (McKeeman et al., 2004)

    Your Bibliography: McKeeman, G., Ardill, J., Caldwell, C., Hunter, A. and McClure, N., 2004. Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. American Journal of Obstetrics and Gynecology, 191(4), pp.1240-1246.

  • Journal

    Tsatsaris, V., Goffin, F., Munaut, C., Brichant, J., Pignon, M., Noel, A., Schaaps, J., Cabrol, D., Frankenne, F. and Foidart, J.

    Overexpression of the Soluble Vascular Endothelial Growth Factor Receptor in Preeclamptic Patients: Pathophysiological Consequences

    2003 - The Journal of Clinical Endocrinology & Metabolism

    In-text: (Tsatsaris et al., 2003)

    Your Bibliography: Tsatsaris, V., Goffin, F., Munaut, C., Brichant, J., Pignon, M., Noel, A., Schaaps, J., Cabrol, D., Frankenne, F. and Foidart, J., 2003. Overexpression of the Soluble Vascular Endothelial Growth Factor Receptor in Preeclamptic Patients: Pathophysiological Consequences. The Journal of Clinical Endocrinology & Metabolism, 88(11), pp.5555-5563.

  • Journal

    VUORELA, P., HELSKE, S., HORNIG, C., ALITALO, K., WEICH, H. and HALMESMÄKI, E.

    Amniotic Fluid–Soluble Vascular Endothelial Growth Factor Receptor-1 in Preeclampsia

    2000 - Obstetrics & Gynecology

    In-text: (VUORELA et al., 2000)

    Your Bibliography: VUORELA, P., HELSKE, S., HORNIG, C., ALITALO, K., WEICH, H. and HALMESMÄKI, E., 2000. Amniotic Fluid–Soluble Vascular Endothelial Growth Factor Receptor-1 in Preeclampsia. Obstetrics & Gynecology, 95(3), pp.353-357.

  • Journal

    Zhou, Y., McMaster, M., Woo, K., Janatpour, M., Perry, J., Karpanen, T., Alitalo, K., Damsky, C. and Fisher, S. J.

    Vascular Endothelial Growth Factor Ligands and Receptors That Regulate Human Cytotrophoblast Survival Are Dysregulated in Severe Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome

    2002 - The American Journal of Pathology

    In-text: (Zhou et al., 2002)

    Your Bibliography: Zhou, Y., McMaster, M., Woo, K., Janatpour, M., Perry, J., Karpanen, T., Alitalo, K., Damsky, C. and Fisher, S., 2002. Vascular Endothelial Growth Factor Ligands and Receptors That Regulate Human Cytotrophoblast Survival Are Dysregulated in Severe Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome. The American Journal of Pathology, 160(4), pp.1405-1423.

Click here to start building your own bibliography
Keep on Citing!
Cite This For Me:
The Easiest Tool to Create your Bibliographies Online
Join Us!

Save Time and Improve Your Marks with Cite This For Me

10,587 students joined last month!

  • ✔ Save your bibliographies for longer
  • ✔ Quick and accurate citation program
  • ✔ Save time when referencing
  • ✔ Make your student life easy and fun
  • ✔ Pay only once with our Forever plan
  • ✔ Use plagiarism checker
  • ✔ Create and edit multiple bibliographies
Join